SINOVAC BIOTECH LTD Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q4 2018 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Sinovac Biotech Ltd quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q4 2018 to Q4 2023.
- Sinovac Biotech Ltd Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending December 31, 2023 was $6.04M, a 45.5% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)